Clinical Trials Directory

Trials / Completed

CompletedNCT04189653

Clinical Outcomes After Implementation of COntinuous Vital Sign Monitoring On the General Ward.

Clinical Outcomes After Implementation of Continuous Vital Sign Monitoring on the General Ward.

Status
Completed
Phase
Study type
Observational
Enrollment
3,896 (actual)
Sponsor
Radboud University Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In 2018, continuous monitoring (CM) of 5 vital signs with a wearable device, including automated MEWS calculation within the EMR were introduced on the surgical and internal medicine ward of our hospital. Rather than taking the measurements manually, this enabled the nurses to periodically validate the continuously derived vital signs at the protocolled moments, and simultaneously get an automatically calculated MEWS reading,. Moreover, continuous vital sign monitoring provides single channel alarms and trends of the vital signs in between the regular measurement moments. Compared to periodic manual measurements and registration in the EMR, the continuous vital sign monitoring and automated MEWS calculations in the EMR may result in better identification of clinical deterioration, and may improve clinical outcome. The primary objective of this study is to evaluate changes in total hospital and ward stay, "Total Events" during admission (rapid response team (RRT) calls and unexpected intensive care unit (uICU) admissions and deaths) after implementation of CM on the regular surgical and internal medicine wards. Secondary objective is to evaluate changes in MEWS scores at the moment of the uICU admissions, length of hospital, ward and ICU stay and the proportion of RRT calls that results in a ICU admission.

Conditions

Interventions

TypeNameDescription
OTHERContinuous MonitoringWireless continuous vital sign monitoring (HR, RR, SBP/DBP, SAT)

Timeline

Start date
2018-08-01
Primary completion
2019-08-01
Completion
2020-08-01
First posted
2019-12-06
Last updated
2022-09-07

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT04189653. Inclusion in this directory is not an endorsement.